期刊文献+

强直性脊柱炎患者凝血、纤溶相关指标的临床意义 被引量:10

下载PDF
导出
摘要 目的:探讨强直性脊柱炎(AS)患者凝血、纤溶相关指标的变化及临床意义。方法:测定AS组和健康对照组血浆中凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)、凝血酶时间(TT)、抗凝血酶活性(AT-Ⅲ)、D-二聚体(D-D)等凝血、纤溶相关指标,及红细胞沉降率(ESR)、C反应蛋白(CRP)。结果:AS组D-二聚体,FIB高于对照组(均P<0.05),AS组与对照组其他凝血、纤溶相关指标比较,差异无统计学意义;D-二聚体及FIB升高AS组ESR、CRP明显高于D-二聚体及FIB正常AS组(均P<0.01);相关性分析提示D-二聚体、FIB与ESR、CRP存在相关性。结论:AS患者血中D-二聚体和FIB水平均有升高,且与炎症活动密切相关。
作者 李菁
出处 《交通医学》 2014年第4期356-357,共2页 Medical Journal of Communications
  • 相关文献

参考文献11

  • 1Sieper J,Braun J,Rudwaleit M,et al.Ankylosing spondylitis:an overview[J].Ann Rheum Dis,2002,61(3):8-18.
  • 2Mathieu S,Motreff P,Soubrier M.Spondyloarthropathies:an Independent cardiovascular risk factor[J]?Joint Bone Spine,2010,77(6):542-545.
  • 3Rollefstad S,Kvien TK,Holme I,et al.Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic[J].Ann Rheum Dis,2013,72(12):1968-1974.
  • 4薛红霞,崔华东,刘冬梅,付文轶,刘晓丹,杨丽丽,赵丽娟,张宁.D-二聚体及纤维蛋白原水平在类风湿关节炎中的临床意义[J].中国医科大学学报,2011,40(11):1004-1006. 被引量:30
  • 5李春,穆荣,任立敏,范文强,任长吉,栗占国.D-二聚体水平在系统性红斑狼疮的临床意义[J].中华内科杂志,2010,49(12):1039-1042. 被引量:26
  • 6Vanderlinden SJ,Valkenburg HA,Cats A.Evaluation of diagnostic criteria for ankylosing spondylitis:a proposal for the New York criteria[J].Arthritis Rheum,1984,27(4):361-368.
  • 7Peters MJ,Symmons DP,Mccarey D,et al.EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis[J].Ann Rheum Dis,2010,69(2):325-331.
  • 8张霖,张戈.凝血和纤溶与缺血性心脏病的关系[J].医学综述,2012,18(11):1639-1641. 被引量:7
  • 9So AK,Varisco PA,Kemkes-Matthes B,et al.Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways[J].J Thromb Haemost,2003,1(12):2510-2515.
  • 10Jin T,Bokarewa M,Amu S,et al.Impact of short-term therapies with biologics on prothrombotic biomarkers in rheumatoid arthritis[J].Clin Exp Rheumatol,2009,27(3):491-494.

二级参考文献23

  • 1杨文,初荣,王沈歌,曾倩.老年心脑血管疾病患者与老年及中青年健康者血浆D-二聚体和纤维蛋白原水平的比较(英文)[J].中国临床康复,2005,9(21):230-231. 被引量:12
  • 2Inoh M,Tokuda M,Kiuchi H,et al.Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis.Arthritis Rheum,1996,39:287-291.
  • 3Rajagopalan S,Somers EC,Brook RD,et al.Endothelial cell apoptosis in systemic lupus erythematosus:a common pathway for abnormal vascular function and thrombosis propensity.Blood,2004,103:3677-3683.
  • 4Fijnheer R,Blann AD.The endothelium and coagulopathy in systemic lupus erythematosus:hyperhomocysteinemia as a developing risk factor.J Rheumatol,2003,30:1400-1402.
  • 5Fancher TL,White RH,Kravitz RL.Combined use of rapid D dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis:systematic review.BMJ,2004,329:821.
  • 6Afeltra A,Vadacca M,Conti L,et al.Thrombosis in systemic lupus erythematosus:congenital and acquired risk factors.Arthritis Rheum,2005,53:452-459.
  • 7Bloom BJ,Tucker LB,Miller LC,et al.Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis.J Rheumatol,1998,25:1620-1625.
  • 8Nakashima M,Aoyagi T,Aratake K,et al.The levels of FDP,FDP-E and D-dimer in patients with rheumatoid arthritis.Ryumachi,1998,38:793-800.
  • 9van Hylckama Vlieg A,Montes R,Rosendaal FR,et al.Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis.J Thromb Haemost,2007,5:1449-1454.
  • 10Cotran RS.American Association of Pathologists president's address.New roles for the endothelium in inflammation and immunity.Am J Pathol,1987,129:407-413.

共引文献56

同被引文献112

  • 1刘斌,郭传友,刘文曲,吴宁,邢倩.血沉及C反应蛋白判定强直性脊柱炎病情活动的价值[J].中华内科杂志,2005,44(8):566-569. 被引量:31
  • 2杨永良,王英振.色素沉着绒毛结节性滑膜炎[J].中国矫形外科杂志,2006,14(21):1639-1641. 被引量:11
  • 3雷莹辉,裴志刚,高国红.强直性脊柱炎并发的心脏病变[J].中国疗养医学,2007,16(6):365-365. 被引量:2
  • 4李振彬,杜志峰,杨志霞.通心络胶囊对佐剂性关节炎的影响及其作用机制探讨[J].中国中医基础医学杂志,2007,13(6):428-429. 被引量:4
  • 5王承德,沈丕安,胡荫奇.实用中医风湿病学[M].2版.北京:人民卫生出版社,2009:531,532.
  • 6国家中医药管理局《中华本草》编委会.中华本草(精选本)[M].上海:上海科学技术出版社,1998.2419-2420.
  • 7陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 8Bloom B J, Tucker L B, Miller L C, et al. Fibrin D-di- mer as a marker of disease activity in systemic onset ju- venile rheumatoid arthritis [ J ]. J Rheumatol, 1998,25 (8) :1620-1625.
  • 9van der Linden S, Valkenbnrg H A, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A propos- al for modification of the New York criteria [ J]. Arthritis Rheum, 1984,27(4) :361-368.
  • 10Garrett S, Jenkinson T, Kennedy L G, et al. A new ap- proach to defining disease status in ankylosing spondyli- tis: the Bath ankylosing spondylitis disease activity index [ J ]. J Rheumatol, 1994,21 ( 12 ) : 2286-2291.

引证文献10

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部